Relationship Between Hematocrit Level and Cardiovascular Risk Factors in a Community-Based Population

Journal of Clinical Laboratory Analysis

Volumn 29, Issue 4, 2015, Pages 289-293

  Jin, Yuan Ze ^a   Zheng, Dong Han ^a   Duan, Zhi Ying ^a   Lin, Ying Zi ^a   Zhang, Xue Ying ^a   Wang, Jing Ru ^a   Han, Shuo ^a   Wang, Guo Feng ^a   Zhang, Yi Jing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cardiovascular diseases; Community based population; Hematocrit; Middle aged adults; Risk factors

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SODIUM; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BLOOD ANALYSIS; BODY MASS; CARDIOVASCULAR RISK; CHINA; CHOLESTEROL BLOOD LEVEL; COMMUNITY SAMPLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HIGH RISK POPULATION; HUMAN; INTERMEDIATE RISK POPULATION; LIPID ANALYSIS; LOW RISK POPULATION; MALE; MIDDLE AGED; POPULATION AND POPULATION RELATED PHENOMENA; QUESTIONNAIRE; RISK; RISK ASSESSMENT; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; ULTRALOW RISK GROUP; URINALYSIS; WAIST CIRCUMFERENCE; BLOOD; CARDIOVASCULAR DISEASE; DEMOGRAPHY; RISK FACTOR;

ADULT; CARDIOVASCULAR DISEASES; FEMALE; HEMATOCRIT; HUMANS; MALE; MIDDLE AGED; RESIDENCE CHARACTERISTICS; RISK FACTORS;

EID: 84937133682     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21767     Document Type: Article

References (32)

1. Chen Y, Graziano JH, Parvez F, et al. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: Prospective cohort study. BMJ 2011;342:d2431.
2. Steinberger J, Daniels SR, Eckel RH, et al. Progress and challenges in metabolic syndrome in children and adolescents: A scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2009;119:628-647.
3. Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011;472:57-63.
4. Deaton C, Froelicher ES, Wu LH, et al. The global burden of cardiovascular disease. Eur J Cardiovasc Nurs 2011;10:S5-S13.
5. May AL, Kuklina EV, Yoon PW. Prevalence of cardiovascular disease risk factors among US adolescents, 1999-2008. Pediatrics 2012;129:1035-1041.
6. Zanazzi M, Fatini C, Farsetti S, et al. Blood rheology and renal transplantation: An intriguing relationship for assessing cardiovascular risk. Transplant Proc 2010;42:1383-1384.
7. Mur Marti T, Villaro Gabarros M, Porta Martinez N, Jaen Manzanera A. Prevalence of chronic renal insufficiency in diabetic type 2 diabetes patients based on the estimated glomerular filtration rate and relation with cardiovascular risk. Med Clin (Barc) 2013;140:395-400.
8. Nishiyama M, Kimijima M, Muto T, Kimura K. Presence of an interaction between smoking and being overweight increases risks of hypertension, diabetes, and cardiovascular disease in outpatients with mood disorders. Environ Health Prev Med 2012;17:285-291.
9. Salazar Vazquez BY, Martini J, Chavez Negrete A, et al. Cardiovascular benefits in moderate increases of blood and plasma viscosity surpass those associated with lowering viscosity: Experimental and clinical evidence. Clin Hemorheol Microcirc 2010;44:75-85.
10. Tikhomirova IA, Oslyakova AO, Mikhailova SG. Microcirculation and blood rheology in patients with cerebrovascular disorders. Clin Hemorheol Microcirc 2011;49:295-305.
11. Church TS, Lavie CJ, Milani RV, Kirby GS. Improvements in blood rheology after cardiac rehabilitation and exercise training in patients with coronary heart disease. Am Heart J 2002;143:349-355.
12. Lowe GD. Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture. Br J Haematol 2006;133:232-250.
13. 2) as a predictor of mortality in patients with sepsis. Ann Emerg Med 2010;55:40-46.e41.
14. Resch H, Garhofer G, Fuchsjäger-Mayrl G, Hommer A, Schmetterer L. Endothelial dysfunction in glaucoma. Acta Ophthalmol 2009;87:4-12.
15. Dominguez-Rodriguez A, Abreu-Gonzalez P, Sanchez-Sanchez JJ, Kaski JC, Reiter RJ. Melatonin and circadian biology in human cardiovascular disease. J Pineal Res 2010;49:14-22.
16. Pérez-López FR, Larrad-Mur L, Kallen A, Chedraui P, Taylor HS. Review: Gender differences in cardiovascular disease: Hormonal and biochemical influences. Reprod Sci 2010;17:511-531.
17. Skretteberg PT, Bodegard J, Kjeldsen SE, et al. Interaction between inflammation and blood viscosity predicts cardiovascular mortality. Scand Cardiovasc J 2010;44:107-112.
18. Paul L, Jeemon P, Hewitt J, et al. Hematocrit predicts long-term mortality in a nonlinear and sex-specific manner in hypertensive adults. Hypertension 2012;60:631-638.
19. Surampudi PN, Wang C, Swerdloff R. Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy. Int J Endocrinol 2012;2012:625434.
20. Li G, Hu H, Shi W, et al. Elevated hematocrit in nonalcoholic fatty liver disease: A potential cause for the increased risk of cardiovascular disease? Clin Hemorheol Microcirc 2012;51:59-68.
21. Pasipoularides A. Optimal hematocrit: A Procrustean bed for maximum oxygen transport rate? J Appl Physiol (1985) 2012;113:353-354.
22. Puska P, Nissinen A, Tuomilehto J, et al. The community-based strategy to prevent coronary heart disease: Conclusions from the ten years of the North Karelia project. Annu Rev Public Health 1985;6:147-193.
23. Brooks AC, Guillaumin J, Cooper ES, Couto CG. Effects of hematocrit and red blood cell-independent viscosity on canine thromboelastographic tracings. Transfusion 2014;54:727-734.
24. Nemeth N, Alexy T, Furka A, et al. Inter-species differences in hematocrit to blood viscosity ratio. Biorheology 2009;46:155-165.
25. Romagnoli M, Alis-Pozo R, Martinez-Bello V, et al. Blood rheology effect of submaximal exercise on young subjects. Clin Hemorheol Microcirc 2014;56:111-117.
26. Toss F, Nordstrom A, Nordstrom P. Association between hematocrit in late adolescence and subsequent myocardial infarction in Swedish men. Int J Cardiol 2013;168:3588-3593.
27. Brækkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Hansen J-B. Hematocrit and risk of venous thromboembolism in a general population. The Tromsø Study. Haematologica 2010;95:270-275.
28. van Straten AH, Kats S, Bekker MW, et al. Risk factors for red blood cell transfusion after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2010;24:413-417.
29. Solomon SD, Uno H, Lewis EF, et al. Erythropoietic response and outcomes in kidney disease and type 2 diabetes. New Engl J Med 2010;363:1146-1155.
30. Tamariz LJ, Young JH, Pankow JS, et al. Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: The atherosclerosis risk in communities (ARIC) study. Am J Epidemiol 2008;168:1153-1160.
31. Pamukcu B, Oflaz H, Onur I, Cimen A, Nisanci Y. Effect of cigarette smoking on platelet aggregation. Clin Appl Thromb Hemost 2011;17:E175-E180.
32. Castro VM, Clements CC, Murphy SN, et al. QT interval and antidepressant use: A cross sectional study of electronic health records. BMJ 2013;346:f288.